Reference to what was published in the news under “Agility: The drug “Avigan” shows effective results in treating Corona patients”, Agility would like to announce that the results reported in the newspapers were part of an integrated clinical trial to study the drug Avigan®, prepared by Global Response Aid (GRA), an associate company of Agility, and Dr. Reddy’s Laboratories. No material information is available at the moment.

Financial Impact :There is no financial impact at the moment.


Best Regards,

Investor Relations Team

Latest Financial News


June 15, 2022

Confirmation of Corporate Action Dates

Dear Investor, Agility would like to confirm the corporate action dates as per the template. Agility’s General Assembly meeting has …


June 5, 2022

Agility’s New Board Structure

Based on the resolution of Agility’s General Assembly Meeting that was held on May 16, 2022, Agility’s new board structure …


June 1, 2022

Supplement Disclosure: Recommended Cash offer for John Menzies

The board of John Menzies PLC has announced that its shareholders have voted to support a recommended cash offer by …


May 31, 2022

Agility’s Adjourned Extra Ordinary General Assembly Meeting

Dear Investor, Agility Public Warehousing Company KSCP held its Extra Ordinary General Assembly Meeting on Monday May 30th2022 through electronic …